The American journal of gastroenterology

publication venue for

Adenosquamous carcinoma in Barrett's esophagus presenting as pseudoachalasia. 1999
Behavioral treatment of intractable chest pain in a patient with vigorous achalasia. 1988
From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women. 2024
Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-term Maintenance Study. 2023
Maternal and Neonatal Outcomes in Vedolizumab and Ustekinumab Exposed Pregnancies: Results from the PIANO registry. 2023
Management of Lower Gastrointestinal Bleeding. 2023
Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular Carcinoma.. 118. 2023
ENDOSCOPIC DIAGNOSIS OF A DISCONNECTED PANCREATIC DUCT. 2023
Interrater Reliability of Functional Lumen Imaging Probe Panometry and High-Resolution Manometry for the Assessment of Esophageal Motility Disorders.. 118. 2023
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results from the SUCCESS Consortium. 2022
Management of Patients With Acute Lower Gastrointestinal Bleeding: An Updated ACG Guideline.. 118. 2022
Longitudinal Assessment of Bile Duct Loss in Primary Biliary Cholangitis.. 117. 2022
Early Liver Transplantation for Severe Alcohol-Associated Hepatitis and a History of Prior Liver Decompensation.. 117. 2022
Ending Disparities in Liver Transplantation: The Time to Act Is Now.. 117. 2022
Gastroenterology Clinical Trials Transparency: An Analysis of Publication Rates From the ClinicalTrials.gov Database.. 117. 2022
The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study. 2021
Classifying Esophageal Motility by FLIP Panometry: A Study of 722 Subjects With Manometry.. 116. 2021
Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.. 116. 2021
Donald O. Castell (1935-2021): A Life Dedicated to Investigation, Mentoring, and Education.. 116. 2021
Contraction Reserve With Ineffective Esophageal Motility on Esophageal High-Resolution Manometry is Associated With Lower Acid Exposure Times Compared With Absent Contraction Reserve.. 115. 2020
Gastrointestinal Bleeding in Patients With Coronavirus Disease 2019: A Matched Case-Control Study.. 115. 2020
I Smell Smoke-The Must Know Details About the N95.. 115. 2020
Use of the Multiplex Diagnostic PCR Panel in Diarrheal Disease: Expert Guidance on the Interpretation of Results With a Focus on Travelers' Diarrhea.. 115. 2020
Preparation in the Big Apple: New York City, a New Epicenter of the COVID-19 Pandemic.. 115. 2020
Early Paracentesis in High-Risk Hospitalized Patients: Time for a New Quality Indicator.. 114. 2019
Cirrhosis as a Comorbidity in Conditions Subject to the Hospital Readmissions Reduction Program.. 114. 2019
Fragmented Care is Prevalent Among Inflammatory Bowel Disease Readmissions and is Associated With Worse Outcomes.. 114. 2019
To Scope or Not to Scope? The Safety of Upper Endoscopy in the Setting of Pulmonary Embolism.. 114. 2019
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.. 113. 2018
NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.. 113. 2018
Setting Up An Endobariatric Weight Loss Program.. 113. 2018
Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer.. 113. 2018
The Natural History of Severe Acute Liver Injury.. 112. 2017
Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial.. 112. 2017
Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial.. 112. 2016
The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium.. 111. 2016
Leadership in medicine: do we need a new approach?. 109. 2014
Prediction of malignancy in cystic neoplasms of the pancreas: a population-based cohort study.. 109. 2013
Biliary self-expandable metal stents do not adversely affect pancreaticoduodenectomy.. 108. 2013
Guidelines for the diagnosis and management of gastroesophageal reflux disease.. 108. 2013
A dual-action, low-volume bowel cleanser administered the day before colonoscopy: results from the SEE CLEAR II study.. 108. 2013
Quality commitment: the newly established American College of Gastroenterology Quality Council to meet the needs of clinical gastroenterology.. 108. 2013
Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.. 108. 2012
Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States.. 106. 2011
Feasibility and yield of screening in relatives from familial pancreatic cancer families.. 106. 2011
Differential expression of toll-like receptors in patients with irritable bowel syndrome.. 106. 2010
The new health-care law and what it means for clinical gastroenterology.. 105. 2010
Mentoring in gastroenterology.. 105. 2010
Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity.. 105. 2010
Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation?. 105. 2010
Cognitive function does not worsen during long-term low-dose peginterferon therapy in patients with chronic hepatitis C.. 105. 2010
Report of the Multisociety Task Force on GI Training.. 104. 2009
Improved oral intake after palliative duodenal stenting for malignant obstruction: a prospective multicenter clinical trial.. 104. 2009
Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort.. 104. 2009
Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy.. 104. 2009
Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.. 104. 2009
The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.. 104. 2009
Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors.. 103. 2008
Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C.. 103. 2008
Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.. 103. 2008
Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.. 103. 2007
Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study.. 103. 2007
Mechanical lithotripsy of pancreatic and biliary stones: complications and available treatment options collected from expert centers.. 102. 2007
ABIM recertification in gastroenterology: ACG's contribution.. 102. 2007
Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: a randomized and blinded comparison.. 101. 2006
Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis.. 101. 2006
Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.. 101. 2006
Receipt of recommended therapy by patients with advanced colorectal cancer.. 101. 2006
Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life.. 101. 2006
Endoscopic treatment for atypical manifestations of gastroesophageal reflux disease.. 101. 2006
Symptom and function heterogenicity among patients with distal esophageal spasm: studies using combined impedance-manometry.. 101. 2006
A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis C.. 100. 2005
Prospective trial of endoscopic clips versus combination therapy in upper GI bleeding (PROTECCT--UGI bleeding).. 100. 2005
The spectrum of chronic hepatitis C virus infection in the Virginia Correctional System: development of a strategy for the evaluation and treatment of inmates with HCV.. 100. 2005
Gastroesophageal junction smooth muscle remodeling after endoluminal gastroplication.. 99. 2004
Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALT.. 99. 2004
Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis.. 99. 2004
Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients.. 99. 2004
Endoscopic appraisal of the gastroesophageal valve after antireflux surgery.. 99. 2004
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.. 98. 2003
Safety of ERCP during pregnancy.. 98. 2003
Effect of different swallow time intervals on the nutcracker esophagus.. 98. 2003
Celiac disease and irritable bowel-type symptoms.. 97. 2002
Endoluminal delivery of radiofrequency energy to the gastroesophageal junction in uncomplicated GERD: efficacy and potential mechanism of action.. 97. 2002
Role of GERD in chronic resistant sinusitis: a prospective, open label, pilot trial.. 97. 2002
A population-based cohort study comparing laparoscopic cholecystectomy and open cholecystectomy.. 97. 2002
Colorectal cancer screening compliance by medicine residents: perceived and actual.. 96. 2001
Gastric myoelectrical activity and its relationship to the development of nausea and vomiting after intensive chemotherapy and autologous stem cell transplantation.. 96. 2001
Or is it just a little relaxation?. 96. 2001
Assessment of gastric emptying using a low fat meal: establishment of international control values.. 95. 2000
Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.. 95. 2000
Pancreatic duct stents for "obstructive type" pain in pancreatic malignancy.. 95. 2000
Congenital esophageal stenosis in adults.. 95. 2000
Probiotics and immune response.. 95. 2000
How does colorectal cancer present? Symptoms, duration, and clues to location.. 94. 1999
Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with gastroesophageal reflux disease.. 94. 1999
Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms.. 94. 1999
Abnormalities of serum amylase and lipase in HIV-positive patients.. 94. 1999
Gastroesophageal reflux--is it hereditary?. 93. 1998
Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors.. 93. 1998
Laparoscopic antireflux surgery in the elderly.. 93. 1998
The ambulatory pH study is normal, but the patient is not--the importance of the symptoms index.. 93. 1998
The prevalence of intestinal metaplasia in patients with and without peptic strictures.. 93. 1998
The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis.. 92. 1997
Thiamine status in patients receiving long-term home parenteral nutrition.. 91. 1996
Evaluation and management of postfundoplication dysphagia.. 91. 1996
Chronic hepatitis C in patients with sickle cell disease.. 91. 1996
Clinical features of type III (mixed) paraesophageal hernia.. 91. 1996
An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation.. 91. 1996
Postsurgical bile leaks: endoscopic obliteration of the transpapillary pressure gradient is enough.. 90. 1995
Disorders of the rectus abdominis muscle and sheath: a 22-year experience.. 90. 1995
The relationship between insurance class and severity of presentation of inflammatory bowel disease in children.. 90. 1995
The preoperative evaluation of patients considered for laparoscopic antireflux surgery.. 90. 1995
Pseudocyst drainage predisposes to infection when pancreatic necrosis is unrecognized.. 89. 1994
Prolonged ambulatory antroduodenal manometry in humans.. 89. 1994
Delayed gastric emptying of both the liquid and solid components of a meal in chronic liver disease.. 89. 1994
Once an ulcer, always an ulcer?. 89. 1994
Characterization of swallowing and defecation in Parkinson's disease.. 89. 1994
Esophageal carcinoma and achalasia: another call for screening?. 88. 1993
Is the chronic cougher a refluxer?. 87. 1992
Percutaneous endoscopic gastrostomy with jejunal extension: a new technique.. 87. 1992
Gastroesophageal reflux aspiration management--is there a tarnish on cold steel?. 86. 1991
Pressures or volumes in gastroesophageal reflux disease: which is most important?. 85. 1990
Ambulatory esophageal and hypopharyngeal pH monitoring in patients with hoarseness.. 85. 1990
Treatment of candida esophagitis in AIDS patients.. 83. 1988
Gastric heterotopia of the proximal esophagus: a report of four cases detected by endoscopy and review of literature.. 81. 1986
Abnormal esophageal pressures in reflux esophagitis: cause or effect?. 81. 1986
Severe gastroduodenal ulcerations complicating hepatic artery infusion chemotherapy for metastatic colon cancer.. 81. 1986
Comparative study of diarrhea associated with clindamycin and ampicillin therapy.. 73. 1980
Spntaneous perforation of the gastrointestinal tract in patients with cancer.. 63. 1975
Endoscopy in the Peutz-Jeghers syndrome.. 61. 1974
Bloody ascites: diagnostic implications.. 52. 1969
Fragmentation in Cirrhosis: The Excluded May Reveal the Full Story.. 114. 2019
Antibodies to Mitotic Apparatus: New Association With Cholestatic Liver Disease.. 110. 2015
Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease.. 110. 2015
Gadofosveset--a blood pool contrast agent used with MRI to detect obscure gastrointestinal bleeding: a case report.. 107. 2012
Utility of fecal calprotectin in differentiating active inflammatory bowel disease from coexistent irritable bowel syndrome.. 106. 2011
Are all symptoms in patients in IBD due to occult inflammation?. 105. 2010
A rare case of duodenal immunoglobulin m infiltration in a patient with chronic lymphocytic leukemia.. 104. 2009
The first reported case of nodular lymphocyte-predominant Hodgkin's lymphoma of the appendix.. 104. 2009
Once daily trientine for maintenance therapy of Wilson disease.. 103. 2008
Getting categorical on GERD.. 102. 2007
Avoidance of steroids by the early use of infliximab and 6-mercaptopurine in an adolescent with active Crohn's colitis.. 96. 2001
Internal stents and postsurgical bile leaks.. 91. 1996
Ketorolac-associated upper gastrointestinal hemorrhage.. 89. 1994
Gallstones and colon cancer.. 88. 1993
Outcomes of treatment in achalasia: subjective or objective endpoints? 2003
Grading the gastroenterologist and the esophagitis. 2003
Response to Haseeb et al. 2022
Regarding "Increased Risk of COVID-19 in Patients Taking Proton Pump Inhibitors". 2020
Response to He et al. 2019
Response to Franciosa et al. and Triadafilopoulos. 2013
Response to Savarino et al. 2013
Encouraging the best and brightest to pursue careers in academic gastroenterology. 2010
Pneumatic dilatations for achalasia: a safe and effective choice for most patients. 2006
Baclofen facilitates PEG placement in paraplegia-in-flexion syndrome. 2006
Reanalysis of intragastric pH results based on updated correction factors for Slimline and Zinetics 24 single-use pH catheters. 2006
Nocturnal acid breakthrough in subjects taking PPI b.i.d. 1999
Acid control and regression of Barrett's esophagus: is the glass half full or half empty? 1997
Participate and collaborate. 2011
Recognizing challenges, expanding horizons: doing what is required. 2010
Report of the 1993 Gastroenterology Leadership Council Training Director's Conference. 1994
Reflux Monitoring in Lung Disease: Is There a Better Metric than Esophageal Acid Exposure Time?. 117. 2022
Editorial: Treatment of patients with HCV-related cirrhosis with peginterferon and ribavirin: Swinging the pendulum toward treatment.. 105. 2010
Telemetry capsule for ambulatory pH monitoring: is it time for a change?. 103. 2008
Antireflux surgery: who needs it?. 98. 2003
Small bowel bacterial overgrowth, celiac disease, and IBS: what are the real associations?. 98. 2003
Autism and the gastrointestinal tract.. 95. 2000
The North American Conference of GI Fellows: medicine and the pharmaceutical industry at its best.. 89. 1994
Achalasia: two effective treatment options--let the patient decide.. 89. 1994
Gastroesophageal reflux disease: the roles of motility in pathophysiology and therapy.. 88. 1993
24-h pH monitoring for gastroesophageal reflux disease: already standard but not yet gold?. 87. 1992
Use of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis. 2020
Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis. 2019
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. 2015
The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. 2014
Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. 2014
Radiation exposure in gastroenterology: improving patient and staff protection. 2014
Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. 2009
An evidence-based position statement on the management of irritable bowel syndrome. 2009
Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy. 2007
Systematic review on the management of chronic constipation in North America. 2005
Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety. 2003
Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux disease. 2003
Systematic review on the management of irritable bowel syndrome in North America. 2002
Splanchnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome. 1996
Granular cell tumor of the stomach: a case report and review of the literature. 1983
Placebo Adverse Events in Non-alcoholic Steatohepatitis Clinical Trials: A Pooled Analysis of 2,944 Participants. 2022
Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis. 2022
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. 2022
Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations. 2021
Is duodenogastroesophageal reflux impliated in Barrett's esophagus? 2002
Do NSAIDs cause dyspepsia? A meta-analysis evaluating alternative dyspepsia definitions. 2002
Approach to the patient with unexplained chest pain. 2000
Treatment of gastroesophageal reflux disease: use of algorithms to aid in management. 1999
Pseudoaneurysm formation after catheter dissection of the common hepatic artery: report of two cases. 1997
Angiosarcoma of the small intestine: a case report and literature review. 1994
Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel. 2018

VIVO Weill Cornell Medical College

The American journal of gastroenterology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)